PharmaEngine Inc (4162):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:PharmaEngine Inc (4162) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7626
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PharmaEngine Inc (PharmaEngine) is a biopharmaceutical company that discovers and develops cancer treatment drugs and related medicinal products. The company develops drugs for the treatment of cancer and Asian prevalent diseases. Its products include Onivyde a liposome encapsulation of irinotecan. PharmaEngine also discovers and develops PEP503, NBTXR3 and PEP06 in lead optimization. The company’s products are used for the treatment of types of cancers such as head cancer, neck cancer, oral cancer, metastatic pancreatic cancer, and colorectal cancer, among others. It has its research and development collaborations with drug discovery companies and drug development companies. PharmaEngine is headquartered in Taipei, Taiwan.

PharmaEngine Inc (4162) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PharmaEngine Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PharmaEngine Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PharmaEngine Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PharmaEngine Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
PharmaEngine Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
PharmaEngine Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Pharmaengine Enters Into Co-Development Agreement With Guangzhou BeBetter Medicine Technology 10
Licensing Agreements 11
Merrimack Pharma Amends Licensing Agreement with PharmaEngine for MM-398 11
Pharmaengine Enters Into Licensing Agreement With Nanobiotix For NBTXR3 13
PharmaEngine Inc – Key Competitors 15
PharmaEngine Inc – Key Employees 16
PharmaEngine Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
PharmaEngine Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
PharmaEngine Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PharmaEngine Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PharmaEngine Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PharmaEngine Inc, Deals By Therapy Area, 2012 to YTD 2018 8
PharmaEngine Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Pharmaengine Enters Into Co-Development Agreement With Guangzhou BeBetter Medicine Technology 10
Merrimack Pharma Amends Licensing Agreement with PharmaEngine for MM-398 11
Pharmaengine Enters Into Licensing Agreement With Nanobiotix For NBTXR3 13
PharmaEngine Inc, Key Competitors 15
PharmaEngine Inc, Key Employees 16
PharmaEngine Inc, Subsidiaries 17

List of Figures
PharmaEngine Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
PharmaEngine Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
PharmaEngine Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
PharmaEngine Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
PharmaEngine Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PharmaEngine Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
PharmaEngine Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PharmaEngine Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[PharmaEngine Inc (4162):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • LG Life Science LTD (068870)-製薬・医療分野:企業M&A・提携分析
    Summary LG Life Science LTD (LGLS) is a global life science company that offers development, production and marketing of pharmaceutical products. The company provides pipeline of antibiotic, Factive and other drug candidates. Its products include vaccines, anti-infective, chemicals, veterinary medic …
  • Patrys Ltd (PAB)-製薬・医療分野:企業M&A・提携分析
    Summary Patrys Ltd (Patrys) is a healthcare company that provides therapeutic products. The company offers product pipeline such as PAT-SC1 used for the treatment of gastric cancer; PAT-SM6, PAT-PA1, and PAT-LM1 used to treat multiple cancers. It develops natural human antibody-based therapeutic pro …
  • Avantium NV (AVTX):企業の財務・戦略的SWOT分析
    Avantium NV (AVTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Alembic Pharmaceuticals Ltd (APLLTD):製薬・医療:M&Aディール及び事業提携情報
    Summary Alembic Pharmaceuticals Ltd (APL) is a pharmaceutical company which manufactures and markets generic pharmaceutical products. The company’s active pharmaceutical ingredients include macrolides, NSAIDs, and other drugs. It also offers branded formulations in the areas of antibiotics and antib …
  • Camel-IDS NV:製薬・医療:M&Aディール及び事業提携情報
    Summary Camel-IDS NV (Camel-IDS) is a biotechnology company that develops radio-immunotherapeutic drugs for cancer patients. The company offers developing of compound radiopharmaceutical drugs for treatment of Her2 positive cancer. Its technology platform is based on recombinant, small antigen-bindi …
  • Bausch Health Companies Inc (BHC):企業の財務・戦略的SWOT分析
    Bausch Health Companies Inc (BHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Forma Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Forma Therapeutics Inc (Forma) is a drug discovery and development company that discovers and develops new transformative cancer therapeutics. The company develops technologies to identify the initial molecules that provide drug discovery program. It offers research in the areas of tumor met …
  • Twist Bioscience Corp (TWST):製薬・医療:M&Aディール及び事業提携情報
    Summary Twist Bioscience Corp (Twist Bioscience) is a provider of synthetic DNA Tools. Its silicon-based DNA synthesis platform enables precise synthesis and sequencing process and production of synthetic DNA tools. The company offers its products which include DNA tools for gRNA cloning such as una …
  • OGK-2 (OGKB):企業の財務・戦略的SWOT分析
    OGK-2 (OGKB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Aozora Bank Ltd:企業の戦略・SWOT・財務情報
    Aozora Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary Aozora Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • One Call Care Management Inc:医療機器:M&Aディール及び事業提携情報
    Summary One Call Care Management Inc (OCCM), formerly One Call Medical Inc, is a healthcare technology provider that provides specialized cost containment services. The company offers diagnostics, dental, transport, complex home care, equipment and physical therapy, among others. It provides value a …
  • PDL BioPharma Inc (PDLI):製薬・医療:M&Aディール及び事業提携情報
    Summary PDL BioPharma Inc (PDL) formerly Protein Design Labs, Inc., manages a portfolio of patents and royalty assets that include Queen et al. patents and license agreements with various pharmaceutical and biotechnology companies, and royalty and other acquired assets. It offers financing solutions …
  • Suncorp Group Ltd:戦略・SWOT・企業財務分析
    Suncorp Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Suncorp Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Abercrombie & Fitch Co:企業の戦略・SWOT・財務分析
    Abercrombie & Fitch Co - Strategy, SWOT and Corporate Finance Report Summary Abercrombie & Fitch Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Awilco LNG ASA (ALNG):石油・ガス:M&Aディール及び事業提携情報
    Summary Awilco LNG ASA (Awilco LNG), a subsidiary of Awilhelmsen AS, is an oil and gas company that provides LNG transportation programs. The company owns and operates LNG vessels intended for international trading. It offers LNG value chain such as liquefaction, production, regasification, transpor …
  • MetLife Inc:戦略・SWOT・企業財務分析
    MetLife Inc - Strategy, SWOT and Corporate Finance Report Summary MetLife Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Australian Agricultural Company Limited:企業の戦略・SWOT・財務情報
    Australian Agricultural Company Limited - Strategy, SWOT and Corporate Finance Report Summary Australian Agricultural Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Saudi Airlines Catering:企業の戦略・SWOT・財務分析
    Saudi Airlines Catering - Strategy, SWOT and Corporate Finance Report Summary Saudi Airlines Catering - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Lantronix, Inc. (LTRX):企業の財務・戦略的SWOT分析
    Lantronix, Inc. (LTRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Noven Pharmaceuticals Inc:企業の戦略的SWOT分析
    Noven Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆